Rozlany chłoniak z dużych komórek B: badanie fazy III leku rituximab i doxorubicin hydrochloride
A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse…